Inhibition of complement factor C5a or C5aR for cholesterol crystal embolism-related vascular thrombosis with microvascular injury and its consequences.
Zhao D, Han C, Mammadova-Bach E, Watanabe-Kusunoki K, Bandeira Honda TS, Li Y, Li C, Li Q, Long H, Lyubenov L, Shi C, Santovito D, Weber C, Boor P, Droste P, Parikh S, Shapiro J, De Chiara L, Carangelo G, Romagnani P, Klussmann S, Hoehlig K, Vater A, Anders HJ.
Zhao D, et al.
Kidney Int. 2024 Nov;106(5):819-825. doi: 10.1016/j.kint.2024.07.020. Epub 2024 Aug 12.
Kidney Int. 2024.
PMID: 39142565
Free article.